Walgreens Boots falls

Walgreens Boots falls after quarterly dividend suspension
Walgreens Boots Alliance (NASDAQ:WBA) fell over 7% in extended trading on Thursday after the drugstore chain said it is suspending cash dividend paid to stockholders on a quarterly basis. This comes after a report that a potential takeover of the company by private equity from Sycamore Partners will likely not happen.
Walgreens suspends quarterly dividend amid turnaround efforts
Walgreens Boots Alliance has suspended its quarterly cash dividend amid restructuring efforts, the U.S. pharmacy chain operator said on Thursday, sending its shares down nearly 8% in extended trading.
Walgreens Suspends Nearly Century-Old Dividend to Save Cash
Walgreens Boots Alliance Inc. is suspending the quarterly dividend it’s paid for the past 92 years in a bid to conserve cash as the troubled pharmacy chain attempts to revive the business.Most Read fr
Walgreens Boots Alliance suspends quarterly dividend
Walgreens Boots Alliance (WBA) announced that its board of directors is suspending the company’s cash dividend historically paid to
For first time in 92 years, Walgreens suspends quarterly dividend amid financial struggles
Walgreens Boots Alliance announced Thursday that it is suspending its practice of paying cash dividends to stockholders — the first time it won’t pay a quarterly dividend in 92 years. The change comes amid struggles for the Deerfield-based retail pharmacy giant.
kffhealthnews2d
Walgreens Unlikely To Sell To Private Equity Firm Sycamore Partners
Pharmacy chain Walgreens has been struggling for over a year and has been in talks to sell to Sycamore Partners, a deal that is now "mostly dead." Meanwhile, some independent pharmacies are opting to ...
Becker's Hospital Review3d
Walgreens private equity sale 'mostly dead': Report
Sources told CNBC's David Faber that a private equity firm's prospective deal to acquire Walgreens Boots Alliance is ...
Drug Store News3d
Walgreens buyout talks reportedly unlikely to culminate in a deal
A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...
Why Walgreens Boots Alliance Stock Sank by Almost 5% Today
Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...
Crain's Chicago Business3d
Walgreens stock tumbles on report that private equity deal is unlikely
Shares of Walgreens Boots Alliance tumbled today following a CNBC report that the Deerfield-based pharmacy chain was unlikely ...
Hold Rating Maintained for Walgreens Boots Alliance Amid Acquisition Uncertainty and Legal Challenges
Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Walgreens Boots Alliance (WBA – Research Report), retaining the price ...
Forbes20d
Walgreens Pharmacy Strength And CEO Comments Toss Cold Water On Private Equity Deal
Walgreens continues to discount that report ... drive long-term value indicate that the rumored sale to PE firm Sycamore Partners is less likely." Mizuho Securities USA analyst Ann Hynes, too ...
Walgreens Stock Falls on Concerns Potential Buyout Deal is ‘Dead’
Shares of Walgreens Boots Alliance tumbled after a report that the pharmacy chain’s talks to sell itself to a private-equity firm are unlikely to result in a deal. CNBC’s David Faber said on air his s ...
Walgreens Boots slides after CNBC’s Faber calls Sycamore deal ‘mostly dead’
Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...